| Element List | Explanation |
|---|---|
| Introduction | With reference to the announcement by Almujtama Alraida Medical Co. published on the Saudi Stock Exchange (Tadawul) website on 15-05-1447 AH (06-11-2025 AD) regarding the signing of an exclusive commercial distribution agreement, the company wishes to clarify some details for its shareholders. |
| Date of Posting the Previous Announcement of Development on Saudi Exchange’s Website | 2025-11-06 Corresponding to 1447-05-15 |
| Hyperlink to the Previous Announcement | Click Here |
| Change on the Development | Contract signing date: 15-05-1447 AH, corresponding to 06-11-2025 AD Contract Value: The agreement is a distribution agreement for GSS products within the Kingdom of Saudi Arabia for five brands – one brand whose profits are entirely for the Almujtama Alraida Medical Company, and the remaining brands (4 brands) have profits and losses shared equally between the two parties. Contract Duration: This agreement has a total duration of eight years from the date of signing, divided into two operational phases. Phase One, lasting three years: It was agreed that profits and losses would be shared equally between the two parties. Phase Two, lasting five years: Almujtama Alraida Medical Co. will have the exclusive right to distribute GSS's products and receive all profits. The agreement may be renewed by written agreement between the parties. |
| Financial Impact on the change | The financial impact is expected to be reflected in the annual financial statements for fiscal year 2026. |